基于蛋白质的COVID-19疫苗的审查:从单价值到多价值配方
Gui Qian1, Cuige Gao1, Miaomiao Zhang1
1Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing 100176, China.
Vaccines
|June 27, 2024
概括
基于多价值蛋白质的COVID-19疫苗可能会对SARS-CoV-2变种提供更广泛的保护. 本综述探讨了它们的发展,比较了提高疫苗疗效的单价和多价策略.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 由SARS-CoV-2引起的COVID-19大流行,需要快速开发疫苗.
- 基于蛋白质的疫苗提供安全性和有针对性的免疫反应.
- 病毒突变对疫苗有效性提出了持续的挑战.
研究的目的:
- 审查基于蛋白质的COVID-19疫苗的开发.
- 分析从单价疫苗配方向多价疫苗配方的转变.
- 评估不同基于蛋白质的疫苗策略的疗效和特征.
主要方法:
- 关于基于蛋白质的COVID-19疫苗开发的文献综述.
- 综合关于疫苗制造商和抗原成分的数据.
- 对单价和多价疫苗的临床试验结果的分析.
主要成果:
- 基于蛋白质的疫苗已经显示出希望,但SARS-CoV-2的演变带来了挑战.
- 单价和多价疫苗策略正在研究中,有效性各不相同.
- 合成了有关制造商,抗原和临床结果的数据.
结论:
- 假设多价值疫苗策略可以提供针对SARS-CoV-2的增强,广泛的保护.
- 需要进一步的研究才能充分了解单价和多价蛋白质疫苗的比较有效性.
更多相关视频
12:09Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
42.8K
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
3.6K
相关概念视频
Conjugated Proteins
18.3K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.3K
Vaccinations
44.4K
Overview
44.4K
